15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Impact of achieved blood pressure on renal function decline and first stroke in hypertensive patients with chronic kidney disease

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: not found
          • Article: not found

          Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK Trial

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

            Many cases of end-stage renal disease (ESRD) are ascribed to hypertension. However, because renal disease itself can raise blood pressure, some investigators argue that ESRD seen in patients with hypertension is due to underlying primary renal disease. Previous cohort studies of the relationship between blood pressure and ESRD did not uniformly screen out baseline kidney disease. We conducted a historical cohort study among members of Kaiser Permanente of Northern California, a large integrated health care delivery system. The ESRD cases were ascertained by matching with the US Renal Data System registry. A total of 316 675 adult Kaiser members participated in the Multiphasic Health Checkups from 1964 to 1985. All subjects had estimated glomerular filtration rates of 60 mL /min per 1.73 m(2) or higher and negative dipstick urinalysis results for proteinuria or hematuria. During 8 210 431 person-years of follow-up, 1149 cases of ESRD occurred. Compared with subjects with a blood pressure less than 120/80 mm Hg, the adjusted relative risks for developing ESRD were 1.62 (95% confidence interval [CI], 1.27-2.07) for blood pressures of 120 to 129/80 to 84 mm Hg, 1.98 (95% CI, 1.55-2.52) for blood pressures of 130 to 139/85 to 89 mm Hg, 2.59 (95% CI, 2.07-3.25) for blood pressures of 140 to 159/90 to 99 mm Hg, 3.86 (95% CI, 3.00-4.96) for blood pressures of 160 to 179/100 to 109 mm Hg, 3.88 (95% CI, 2.82-5.34) for blood pressures of 180 to 209/110 to 119 mm Hg, and 4.25 (95% CI, 2.63-6.86) for blood pressures of 210/120 mm Hg or higher. Similar associations between blood pressure level and ESRD risk were seen in all subgroup analyses. Even relatively modest elevation in blood pressure is an independent risk factor for ESRD. The observed relationship does not appear to be due to confounding by clinically evident baseline kidney disease.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Blood Pressure Control, Proteinuria, and the Progression of Renal Disease

                Bookmark

                Author and article information

                Journal
                Nephrology Dialysis Transplantation
                Oxford University Press (OUP)
                0931-0509
                1460-2385
                March 2018
                March 01 2018
                September 19 2017
                March 2018
                March 01 2018
                September 19 2017
                : 33
                : 3
                : 409-417
                Affiliations
                [1 ]Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, China
                [2 ]Department of Cardiology, Peking University First Hospital, Beijing, China
                [3 ]Department of Cardiology, Peking University People’s Hospital, Beijing, China
                [4 ]Department of Pharmacy, Peking University First Hospital, Beijing, China
                [5 ]Department of Neurology, First People’s Hospital, Lianyungang, China
                [6 ]Institute for Biomedicine, Anhui Medical University, Hefei, China
                [7 ]Department of Health Administration, School of Health Administration, Anhui Medical University, Hefei, China
                [8 ]Department of Cardiology, First People’s Hospital, Lianyungang, China
                [9 ]Department of Cardiology, Second Affiliated Hospital, Nanchang University, Nanchang, China
                [10 ]AUSA Research Institute, Shenzhen AUSA Pharmed Co. Ltd, Shenzhen, China
                Article
                10.1093/ndt/gfx267
                29036427
                9cc14f75-3d4b-4561-8d27-e185d9d26c6e
                © 2017
                History

                Comments

                Comment on this article